Elizabeth Donahue is a Senior Director of Project Management in the Peri- and Post-Approval Studies and Real-World Evidence team, PPD, part of Thermo Fisher Scientific. She brings over 18 years of CRO experience to her position. As an operational subject matter expert, Elizabeth is instrumental in the strategic delivery of trials with varying study design, including Phase III clinical trials, observational studies, registries, chart reviews, and long-term follow-up studies. Her therapeutic experience focuses on rare diseases, pediatric studies, and cell and gene therapies, which encompasses multiple indications in endocrinology, hematology, neurology, and more. Elizabeth is also a member of PPD’s Rare Disease and Pediatrics Center of Excellence, a group dedicated to delivering expertise and supporting clinical study teams across a variety of rare indications and those affecting children.
This roundtable discussion will look to discuss:
Sponsored by Thermo Fisher Scientific.